Article
LCK at the crossroad of immunodeficiency and autoimmunity: Mechanisms and therapeutic opportunities.
Immunology letters - 1 Jun 2026
Woessner Nadine M, Keller Baerbel, Minguet Susana
Abstract excerpt
The lymphocyte-specific protein tyrosine kinase (LCK) is the principal initiator of T cell receptor (TCR) signaling and a critical regulator of T-cell development, activation, and immune tolerance. Its critical expression in T cells positions LCK as both a molecular gatekeeper of adaptive immunity and an attractive therapeutic target. Loss-of-function mutations in LCK result in combined immunodeficiency with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
